The low expression of IGFBP2 observed in some glioblastoma cell lines, is associated with methylation of the IGFBP2 promoter and can be restored with 5-azacytadine treatment suggesting regulation by DNA methyltransferase 1 (DNMT1) (94). This evidence concerns the gene IGFBP2 and glioblastoma.